Sarepta Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
November 02 2020 - 4:30PM
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision
genetic medicine for rare diseases, today announced that senior
management will participate in a fireside chat at the 29th Annual
Credit Suisse Virtual Healthcare Conference on Monday, November 9,
2020 at 3:30 p.m. E.T.
The presentation will be webcast live under the
investor relations section of Sarepta’s website at www.sarepta.com
and will be archived there following the presentation for 90 days.
Please connect to Sarepta's website several minutes prior to the
start of the broadcast to ensure adequate time for any software
download that may be necessary.
About Sarepta
TherapeuticsAt Sarepta, we are leading a revolution in
precision genetic medicine and every day is an opportunity to
change the lives of people living with rare disease. The Company
has built an impressive position in Duchenne muscular dystrophy
(DMD) and in gene therapies for limb-girdle muscular dystrophies
(LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth
(CMT), and other CNS-related disorders, with more than 40 programs
in various stages of development. The Company’s programs and
research focus span several therapeutic modalities, including RNA,
gene therapy and gene editing. For more information, please
visit www.sarepta.com or follow us on Twitter, LinkedIn,
Instagram and Facebook.
Internet Posting of
Information
We routinely post information that may be
important to investors in the 'Investors' section of our website
at www.sarepta.com. We encourage investors and potential
investors to consult our website regularly for important
information about us.
Source: Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc.Investors:Ian Estepan, 617-274-4052,
iestepan@sarepta.com
Media:Tracy Sorrentino, 617-301-8566,
tsorrentino@sarepta.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Sep 2023 to Sep 2024